The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, dou (Q34774096)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, dou |
scientific article |
Statements
1 reference
The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, dou (English)
1 reference
Markolf Hanefeld
1 reference
Christie M Ballantyne
1 reference
Emile R Mohler
1 reference
Michael H Davidson
1 reference
Joel L Johnson
1 reference
Andrew Zalewski
1 reference
Darapladib Investigators
1 reference
1 reference
Identifiers
1 reference